Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4782614
Max Phase: Preclinical
Molecular Formula: C19H23NO2
Molecular Weight: 297.40
Molecule Type: Unknown
Associated Items:
ID: ALA4782614
Max Phase: Preclinical
Molecular Formula: C19H23NO2
Molecular Weight: 297.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1cccc(-c2ccc(C(C)N(C)C)cc2)c1
Standard InChI: InChI=1S/C19H23NO2/c1-5-22-19(21)18-8-6-7-17(13-18)16-11-9-15(10-12-16)14(2)20(3)4/h6-14H,5H2,1-4H3
Standard InChI Key: BCTZYVGYOHVINL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 297.40 | Molecular Weight (Monoisotopic): 297.1729 | AlogP: 4.15 | #Rotatable Bonds: 5 |
Polar Surface Area: 29.54 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.08 | CX LogP: 4.34 | CX LogD: 2.66 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -0.77 |
1. Mayer N,Schweiger M,Fuchs E,Migglautsch AK,Doler C,Grabner GF,Romauch M,Melcher MC,Zechner R,Zimmermann R,Breinbauer R. (2020) Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL)., 28 (16): [PMID:32690265] [10.1016/j.bmc.2020.115610] |
Source(1):